Clinical trial
A Phase I/III, Multi-center, Randomized, Double-blind Study of BAT3306 Plus Chemotherapy Versus Keytruda® Plus Chemotherapy to Evaluate Pharmacokinetics, Efficacy, and Safety in Participants With Stage IV Non-squamous Non-small Cell Lung Cancer.
NCT06280196 is registered in ClinicalTrials.gov with Bio-Thera Solutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/III, Multi-center, Randomized, Double-blind Study of BAT3306 Plus Chemotherapy Versus Keytruda® Plus Chemotherapy to Evaluate Pharmacokinetics, Efficacy, and Safety in Participants With Stage IV Non-squamous Non-small Cell Lung Cancer.
- Lead sponsor
- Bio-Thera Solutions
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- July 19, 2024
- Completion date
- July 30, 2025
- Enrollment
- 162 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.